Skip to main content
. 2015 Aug 19;19(1):299. doi: 10.1186/s13054-015-1007-5

Table 3.

Mortality at 30 days and 365 days following admission in 57,110 adult ICU patients with and without atrial fibrillation

AF, % No AF, % Crude RRa Adjusted RRa,b
30-day mortality
Overall 26.8 (25.6–28.0) 16.0 (15.7–16.4) 1.67 (1.59–1.76) 1.04 (0.99–1.10)
Age
  15–54 yr 13.6 (10.0–18.5) 6.1 (5.7–6.4) 2.25 (1.64–3.08) 1.73 (1.29–2.32)
  55–70 yr 16.7 (14.9–18.7) 14.6 (14.1–15.1) 1.14 (1.02–1.29) 1.09 (0.96–1.24)
  71–105 yr 32.6 (31.0–34.2) 28.5 (27.8–29.2) 1.14 (1.08–1.21) 1.04 (0.98–1.10)
Sex
  Female 30.0 (28.0–32.1) 16.7 (16.2–17.2) 1.80 (1.67–1.93) 1.05 (0.97–1.14)
  Male 24.9 (23.4–26.4) 15.5 (15.1–16.0) 1.60 (1.50–1.71) 1.04 (0.97–1.12)
Prior myocardial infarction
  Not present 26.2 (24.9–27.6) 15.6 (15.3–16.0) 1.68 (1.59–1.77) 1.04 (0.98–1.11)
  Present 29.1 (26.4–31.9) 20.0 (18.9–21.1) 1.46 (1.31–1.63) 1.06 (0.93–1.19)
Congestive heart failure
  Not present 24.2 (22.8–25.7) 15.3 (15.0–15.6) 1.58 (1.49–1.69) 1.04 (0.97–1.10)
  Present 31.9 (29.7–34.1) 27.7 (26.2–29.3) 1.15 (1.05–1.26) 1.08 (0.99–1.18)
Mechanical ventilation
  No 24.9 (24.3–25.5) 11.2 (10.9–11.5) 2.10 (1.96–2.26) 1.00 (0.93–1.08)
  Yes 31.3 (29.4–33.3) 23.6 (22.1–25.1) 1.26 (1.18–1.35) 1.12 (1.05–1.20)
Renal replacement therapy
  No 25.9 (24.7–27.1) 15.3 (15.0–15.6) 1.69 (1.60–1.78) 1.04 (0.98–1.09)
  Yes 44.1 (38.2–50.4) 41.7 (39.2–44.3) 1.06 (0.91–1.23) 1.04 (0.88–1.22)
Treatment with inotropes or vasopressors
  No 24.3 (22.8–25.9) 12.1 (11.7–12.4) 2.02 (1.88–2.16) 1.02 (0.94–1.09)
  Yes 30.4 (28.5–32.4) 25.9 (25.2–26.6) 1.17 (1.09–1.26) 1.08 (1.01–1.16)
Non-invasive ventilation
  No 25.2 (24.0–26.5) 14.7 (14.4–15.0) 1.72 (1.63–1.81) 1.06 (1.00–1.12)
  Yes 39.6 (35.7–43.9) 33.3 (31.8–34.8) 1.19 (1.06–1.33) 0.98 (0.88–1.10)
Surgery performed, any type
  No 36.0 (33.9–38.1) 21.2 (20.6–21.7) 1.70 (1.59–1.81) 0.99 (0.93–1.06)
  Yes 20.7 (19.3–22.2) 12.9 (12.5–13.3) 1.60 (1.49–1.73) 1.03 (0.95–1.12)
Cardiac surgery performed
  No 31.9 (30.5–33.3) 17.5 (17.1–17.8) 1.82 (1.74–1.92) 1.02 (0.97–1.08)
  Yes 7.1 (5.7–8.9) 6.3 (5.7–6.9) 1.13 (0.89–1.44) 0.80 (0.52–1.23)
Abdominal surgery performed
  No 26.2 (24.9–27.6) 15.8 (15.5–16.2) 1.65 (1.56–1.75) 1.05 (0.99–1.11)
  Yes 29.6 (26.7 -32.7) 16.7 (16.2–17.7) 1.75 (1.56–1.95) 1.02 (0.91 -1.14)
Orthopaedic surgery performed
  No 26.5 (25.3–27.7) 16.1 (15.7–16.4) 1.65 (1.57–1.74) 1.05 (1.00–1.11)
  Yes 33.3 (27.7–39.7) 15.9 (14.6–17.4) 2.09 (1.71–2.56) 1.03 (0.80–1.31)
Vascular surgery performed
  No 27.2 (25.9–28.4) 16.4 (16.0–16.7) 1.66 (1.58–1.75) 1.04 (0.99–1.10)
  Yes 16.8 (12.0–23.1) 10.4 (9.3–11.6) 1.61 (1.14–2.28) 0.64 (0.31–1.33)
365-day mortality
Overall 40.9 (40.0–42.3) 25.4 (25.0–25.8) 1.61 (1.55–1.67) 1.03 (1.00–1.07)
Age
  15–55 yr 19.9 (15.5–25.3) 9.8 (9.4–10.3) 2.02 (1.57–2.59) 1.34 (1.06–1.69)
  55–71 yr 28.0 (25.8–30.3) 24.8 (24.2–25.5) 1.13 (1.04–1.23) 1.07 (0.98–1.16)
  71–105 yr 48.6 (46.9–50.4) 43.1 (42.4–43.9) 1.13 (1.08–1.17) 1.03 (1.00–1.07)
Sex
  Female 45.6 (43.4–48.9) 25.9 (25.4–26.5) 1.76 (1.67–1.86) 1.07 (1.01–1.13)
  Male 38.1 (36.4–39.8) 25.0 (24.5–25.5) 1.53 (1.45–1.60) 1.01 (0.96–1.05)
Prior myocardial infarction
  Not present 39.9 (38.4–41.5) 24.8 (24.4–25.2) 1.61 (1.55–1.68) 1.02 (0.98–1.07)
  Present 44.7 (41.8–47.8) 31.2 (29.9–32.5) 1.43 (1.33–1.55) 1.07 (0.99–1.16)
Congestive heart failure
  Not present 37.1 (35.5–38.8) 24.2 (23.8–24.6) 1.53 (1.46–1.61) 1.04 (0.99–1.08)
  Present 48.4 (46.0––50.7) 43.8 (42.1–45.6) 1.10 (1.04–1.18) 1.04 (0.98–1.10)
Mechanical ventilation
  No 38.8 (38.1–41.6) 21.1 (20.6–21.5) 1.89 (1.80–1.99) 1.00 (0.95–1.05)
  Yes 42.4 (40.4–44.6) 33.3 (32.6–34.0) 1.27 (1.21–1.34) 1.09 (1.04–1.15)
Renal replacement therapy
  No 39.6 (38.3–41.0) 24.4 (24.1–24.8) 1.62 (1.56–1.68) 1.03 (0.99–1.06)
  Yes 63.4 (59.5–71.2) 59.2 (56.6–61.7) 1.10 (1.00–1.22) 1.04 (0.94–1.15)
Treatment with inotropes or vasopressors
  No 46.6 (39.2–54.6) 28.7 (26.4–31.2) 1.62 (1.35–1.95) 1.00 (0.82–1.21)
  Yes 52.3 (45.1–60.0) 42.9 (40.3–45.6) 1.22 (1.04–1.43) 0.96 (0.82–1.12)
Non-invasive ventilation
  No 47.6 (41.6–54.0) 32.2 (30.3–34.3) 1.48 (1.28–1.71) 0.99 (0.85–1.15)
  Yes 55.3 (45.1–66.0) 48.6 (44.6–52.7) 1.14 (0.92–1.40) 0.96 (0.78–1.18)
Surgery performed, any type
  No 50.1 (47.9–52.3) 30.6 (30.0–31.3) 1.64 (1.56–1.72) 0.96 (0.92–1.01)
  Yes 34.8 (33.1–36.5) 22.2 (21.7–22.6) 1.57 (1.49–1.66) 1.07 (1.02–1.13)
Cardiac surgery performed
  No 47.6 (46.1–49.2) 27.6 (27.2–28.1) 1.72 (1.66–1.79) 1.00 (0.97–1.04)
  Yes 14.9 (12.9–17.3) 10.2 (9.5–10.9) 1.47 (1.25–1.73) 1.11 (0.88–1.40)
Abdominal surgery performed
  No 39.7 (38.3–41.2) 24.7 (24.3–25.1) 1.61 (1.55–1.68) 1.03 (0.99–1.07)
  Yes 46.4 (43.2–49.7) 28.6 (27.7–29.5) 1.62 (1.50–1.75) 1.04 (0.97–1.12)
Orthopaedic surgery performed
  No 40.3 (38.9–41.7) 25.5 (25.1–25.9) 1.58 (1.52–1.64) 1.03 (0.99–1.07)
  Yes 54.4 (48.2–60.9) 24.1 (22.5–25.8) 2.27 (1.98–2.59) 1.11 (0.97–1.27)
Vascular surgery performed
  No 41.2 (39.8–42.6) 25.8 (25.4–26.2) 1.60 (1.54–1.66) 1.02 (0.99–1.06)
  Yes 33.0 (26.6–40.4) 18.0 (16.6–19.5) 1.83 (1.47–2.29) 1.18 (0.88 -1.57)

AF atrial fibrillation, RR relative risk

95 % confidence intervals are given in parentheses

aReference group was non-AF patients within each stratum

bAdjusted for age and sex, comorbidities, and consultations and services provided by the general practitioner